Search Results - "Malmström, Per‐Uno"

Refine Results
  1. 1

    Bladder cancer by Kamat, Ashish M, Prof, Hahn, Noah M, MD, Efstathiou, Jason A, MD, Lerner, Seth P, Prof, Malmström, Per-Uno, Prof, Choi, Woonyoung, PhD, Guo, Charles C, MD, Lotan, Yair, Prof, Kassouf, Wassim, MD

    Published in The Lancet (British edition) (03-12-2016)
    “…Summary Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major…”
    Get full text
    Journal Article
  2. 2

    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019 by Wang, Eugen, Hagberg, Oskar, Malmström, Per-Uno

    Published in PloS one (14-12-2023)
    “…Alzheimer's disease (AD) affects 50 million people worldwide. The immune system plays a major role in the pathogenesis of AD. Several retrospective analyses…”
    Get full text
    Journal Article
  3. 3

    Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome by Mezheyeuski, Artur, Segersten, Ulrika, Leiss, Lina Wik, Malmström, Per-Uno, Hatina, Jiri, Östman, Arne, Strell, Carina

    Published in Scientific reports (14-01-2020)
    “…Little attention was given to the interaction between tumor and stromal cells in urothelial bladder carcinoma (UBC). While recent studies point towards the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014 by Westergren, Dan-Olle, Gårdmark, Truls, Lindhagen, Lars, Chau, Albert, Malmström, Per-Uno

    Published in The Journal of urology (01-11-2019)
    “…While radical cystectomy remains the standard treatment of muscle invasive bladder cancer, the natural history of patients unable or unwilling to receive…”
    Get full text
    Journal Article
  9. 9

    Parallel Proteomic Workflow for Mass Spectrometric Analysis of Tissue Samples Preserved by Different Methods by Holfeld, Aleš, Valdés, Alberto, Malmström, Per-Uno, Segersten, Ulrika, Lind, Sara Bergström

    Published in Analytical chemistry (Washington) (01-05-2018)
    “…Formalin-fixed and paraffin-embedded (FFPE) and optimal cutting temperature (OCT)-embedded and frozen tissue specimens in biobanks are highly valuable in…”
    Get full text
    Journal Article
  10. 10

    Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study by Hemdan, Tammer, Malmström, Per-Uno, Jahnson, Staffan, Segersten, Ulrika

    Published in The Journal of urology (01-12-2015)
    “…Purpose Neoadjuvant chemotherapy before cystectomy is recommended. To our knowledge the subset of patients likely to benefit has not been identified. We…”
    Get full text
    Journal Article
  11. 11

    Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue‐light cytoscopy in transurethral bladder tumour resection for patients with non‐muscle‐invasive bladder cancer in Sweden by Rose, James B., Armstrong, Shannon, Hermann, Gregers G., Kjellberg, Jakob, Malmström, PerUno

    Published in BJU international (01-06-2016)
    “…Objectives To explore the cost impact on Swedish healthcare of incorporating one instillation of hexaminolevulinate hydrochloride (HAL) blue‐light cystoscopy…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer by Türker, Polat, Wernroth, Mona-Lisa, Malmström, Per-Uno, Segersten, Ulrika, Hemdan, Tammer

    “…Clinical utility of cisplatin based neoadjuvant chemotherapy (NAC) prior to radical cystectomy is limited because of lack of tools that can guide for a better…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non–muscle-invasive bladder cancer by Malmström, Per-Uno, Ph.D., M.D, Hemdan, Tammer, Ph.D., M.D, Segersten, Ulrika, Ph.D

    Published in Urologic oncology (01-08-2017)
    “…Abstract Objective The aim of our study was to try to validate 3 promising predictive biomarkers in a database based on prospective trials comparing bacillus…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer by Kerzeli, Iliana K, Kostakis, Alexandros, Türker, Polat, Malmström, Per-Uno, Hemdan, Tammer, Mezheyeuski, Artur, Ward, Douglas G, Bryan, Richard T, Segersten, Ulrika, Lord, Martin, Mangsbo, Sara M

    Published in BMC cancer (30-06-2023)
    “…Urothelial bladder cancer is most frequently diagnosed at the non-muscle-invasive stage (NMIBC). However, recurrences and interventions for intermediate and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy? by Turker, Polat, Segersten, Ulrika, Malmström, Per-Uno, Hemdan, Tammer

    Published in Scandinavian journal of urology (02-01-2019)
    “…Response to neoadjuvant cisplatin treatment in bladder cancer has been linked to expression of Bcl-2 protein by cancer cells. The objective of this study was…”
    Get more information
    Journal Article
  20. 20